Depression treatment and A dynamics: A study of Alzheimer s disease risk

Brief description of study

The purpose of this research study is to test if a reduction in depressive symptoms in response to treatment with an antidepressant improves levels of certain proteins which have been associated with increased risk for the development of Alzheimer's disease (AD).


Clinical Study Identifier: s21-00535
ClinicalTrials.gov Identifier: NCT05004987
Principal Investigator: Nunzio Pomara.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.